Mounjaro is FDA-approved for adults with type 2 diabetes, while Zepbound is FDA-approved for chronic weight management in qualifying adults
Benefits of Mounjaro Mounjaro (tirzepatide), the newest addition to weight management therapies, has shown impressive results in both weight loss and glycemic control, making it a dual-purpose solution
Facial & Aesthetic Enhancement As facial fat decreases, some patients notice skin laxity or fine lines
NAD+ is a coenzyme central to cellular energy metabolism, DNA repair, and mitochondrial function, with downstream antioxidant effects through sirtuins and PARP pathways
A single unit of error at this concentration represents 0.1mg of semaglutide, a meaningful difference especially at lower doses where 0.1mg is a 40% overshoot on a 0.25mg target
Check for potential interactions between GLP-1 medications and your current prescriptions